Bioceres Crop Solutions (BIOX) Cost of Revenue (2016 - 2026)

Bioceres Crop Solutions has disclosed Cost of Revenue across 11 years of filings, most recently posting $26.7 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $26.7 million, down 19.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $164.5 million (down 26.14% YoY), and the FY2025 annual result was $203.4 million, down 26.88% from the prior year.
• Cost of Revenue came in at $26.7 million for Q1 2026 at Bioceres Crop Solutions, down from $47.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $88.7 million in Q4 2023 to a low of $5.3 million in Q2 2022.
• The 5-year median for Cost of Revenue is $49.3 million (2025), against an average of $51.5 million.
• Across the five-year window, Cost of Revenue surged 1124.14% in 2023 and slumped 35.64% in 2025, its largest moves.
• Bioceres Crop Solutions' Cost of Revenue stood at $59.1 million in 2022, then jumped by 50.0% to $88.7 million in 2023, then plunged by 35.45% to $57.3 million in 2024, then slipped by 17.65% to $47.2 million in 2025, then plunged by 43.38% to $26.7 million in 2026.
• The last three Cost of Revenue figures came in at $26.7 million (Q1 2026), $47.2 million (Q4 2025), and $41.3 million (Q3 2025), per Business Quant data.